Nomura Holdings’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-151,750
Closed -$1.14M 1350
2018
Q4
$1.14M Sell
151,750
-50,000
-25% -$352K ﹤0.01% 840
2018
Q3
$1.36M Hold
201,750
﹤0.01% 836
2018
Q2
$1.3M Hold
201,750
﹤0.01% 822
2018
Q1
$1.32M Hold
201,750
﹤0.01% 978
2017
Q4
$1.51M Hold
201,750
﹤0.01% 975
2017
Q3
$1.44M Hold
201,750
﹤0.01% 942
2017
Q2
$1.7M Hold
201,750
﹤0.01% 886
2017
Q1
$1.62M Hold
201,750
﹤0.01% 714
2016
Q4
$1.84M Hold
201,750
﹤0.01% 887
2016
Q3
$1.87M Hold
201,750
0.01% 680
2016
Q2
$2.07M Buy
+201,750
New +$1.85M 0.01% 652

Other funds holding RDY

Nomura Holdings's RDY Position: Q1 2019 in Review

Nomura Holdings sold out of Dr. Reddy's Laboratories (RDY) in Q1 2019, closing a stake of 151,750 shares — an estimated $1.14M sold.

Nomura Holdings first reported a position in RDY in Q2 2016 and held it in 11 quarters. The position peaked at $2.07M in Q2 2016. 143 funds tracked by Wall St. Rank hold RDY as of Q1 2019.

  • Nomura Holdings reported no remaining Dr. Reddy's Laboratories position as of Q1 2019 after selling out during the quarter.
  • Nomura Holdings sold 151,750 Dr. Reddy's Laboratories shares in Q1 2019, an estimated $1.14M.
  • Nomura Holdings first reported a position in Dr. Reddy's Laboratories in Q2 2016 and held it in 11 quarters.
  • Nomura Holdings's Dr. Reddy's Laboratories position peaked at $2.07M in Q2 2016.
  • 143 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2019.

Based on Nomura Holdings's 13F filing for Q1 2019, filed 14 May 2019.